Form D · Biotechnology
Sorrento Therapeutics, Inc.
San Diego, CA · CIK 0000850261
Offering snapshot reported Oct 22, 2013 · SEC filing
- Reported sold
- $1.85M Offering amount: $1.85M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $100 Reported outside-investor minimum
- First sale
- Oct 21, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 22, 2013 | Initial | $1,850,000 | No comparison | 9 | SEC filing |
| Mar 28, 2013 | Initial | $6,418,495 | No comparison | 17 | SEC filing |
| Jan 11, 2012 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Sep 24, 2009 | Initial | $2,000,000 | No comparison | 23 | SEC filing |
| Sep 24, 2009 | Initial | $7,525,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-205019
Source: Form D, filed Oct 22, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ernst Guenter Afting | Director |
| Emst Gunter Afting | Director |
| Ernst Gunter Afting | Director |
| Voung Dr. Trieu | Director, Executive |
| S. James Freedman | Director |
| Cam Gallagher | Director |
| Glenn L. Halpryn | Director |
| Jane H. Hsiao, Ph.D., Mba | Director |
| Kim Janda | Director |
| Kim Janda, Ph.D. | Director |
| Henry Ji | Director, Executive |
| Henry Ji, Ph.D. | Director, Executive |
| Curtis Lockshin | Director |
| Curtis Lockshin, Ph.D. | Director |
| Scott M Salka | Director |
| M. Scott Salka | Director |
| Antonius Schuh | Director, Executive |
| Jaisim Shah | Director |
| Lewis J. Shuster | Director |
| George Uy | Executive |
| Richard G Vincent | Executive |
| David Webb | Director |
| Alan Jay Weisberg | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6042 Cornerstone Ct. West
San Diego, CA, 92121
San Diego, CA, 92121